| Title |
Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, June 2020
|
| DOI | 10.2147/tcrm.s255365 |
| Pubmed ID | |
| Authors |
Yi Li, Yizhao Xie, Chengcheng Gong, Yannan Zhao, Jian Zhang, Sheng Zhang, Leiping Wang, She Chen, Xichun Hu, Biyun Wang |
Mendeley readers
The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 25 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 5 | 20% |
| Student > Doctoral Student | 3 | 12% |
| Other | 2 | 8% |
| Student > Ph. D. Student | 1 | 4% |
| Professor | 1 | 4% |
| Other | 2 | 8% |
| Unknown | 11 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 5 | 20% |
| Agricultural and Biological Sciences | 3 | 12% |
| Social Sciences | 2 | 8% |
| Psychology | 1 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
| Other | 2 | 8% |
| Unknown | 11 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 June 2020.
All research outputs
#6,602,824
of 25,387,668 outputs
Outputs from Therapeutics and Clinical Risk Management
#322
of 1,323 outputs
Outputs of similar age
#142,488
of 433,033 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#3
of 18 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,033 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.